663 related articles for article (PubMed ID: 25261935)
1. Genome-wide analysis of noncoding regulatory mutations in cancer.
Weinhold N; Jacobsen A; Schultz N; Sander C; Lee W
Nat Genet; 2014 Nov; 46(11):1160-5. PubMed ID: 25261935
[TBL] [Abstract][Full Text] [Related]
2. Altered TERT promoter and other genomic regulatory elements: occurrence and impact.
Heidenreich B; Kumar R
Int J Cancer; 2017 Sep; 141(5):867-876. PubMed ID: 28407294
[TBL] [Abstract][Full Text] [Related]
3. Systematic analysis of noncoding somatic mutations and gene expression alterations across 14 tumor types.
Fredriksson NJ; Ny L; Nilsson JA; Larsson E
Nat Genet; 2014 Dec; 46(12):1258-63. PubMed ID: 25383969
[TBL] [Abstract][Full Text] [Related]
4. Analysis of SDHD promoter mutations in various types of melanoma.
Scholz SL; Horn S; Murali R; Möller I; Sucker A; Sondermann W; Stiller M; Schilling B; Livingstone E; Zimmer L; Reis H; Metz CH; Zeschnigk M; Paschen A; Steuhl KP; Schadendorf D; Westekemper H; Griewank KG
Oncotarget; 2015 Sep; 6(28):25868-82. PubMed ID: 26327518
[TBL] [Abstract][Full Text] [Related]
5. A Pan-Cancer Study of Somatic TERT Promoter Mutations and Amplification in 30,773 Tumors Profiled by Clinical Genomic Sequencing.
Gupta S; Vanderbilt CM; Lin YT; Benhamida JK; Jungbluth AA; Rana S; Momeni-Boroujeni A; Chang JC; Mcfarlane T; Salazar P; Mullaney K; Middha S; Zehir A; Gopalan A; Bale TA; Ganly I; Arcila ME; Benayed R; Berger MF; Ladanyi M; Dogan S
J Mol Diagn; 2021 Feb; 23(2):253-263. PubMed ID: 33285287
[TBL] [Abstract][Full Text] [Related]
6. Epigenomic annotation of noncoding mutations identifies mutated pathways in primary liver cancer.
Lowdon RF; Wang T
PLoS One; 2017; 12(3):e0174032. PubMed ID: 28333948
[TBL] [Abstract][Full Text] [Related]
7. Functional annotation of noncoding mutations in cancer.
Umer HM; Smolinska K; Komorowski J; Wadelius C
Life Sci Alliance; 2021 Sep; 4(9):. PubMed ID: 34282050
[TBL] [Abstract][Full Text] [Related]
8. OncoBase: a platform for decoding regulatory somatic mutations in human cancers.
Li X; Shi L; Wang Y; Zhong J; Zhao X; Teng H; Shi X; Yang H; Ruan S; Li M; Sun ZS; Zhan Q; Mao F
Nucleic Acids Res; 2019 Jan; 47(D1):D1044-D1055. PubMed ID: 30445567
[TBL] [Abstract][Full Text] [Related]
9. OncoCis: annotation of cis-regulatory mutations in cancer.
Perera D; Chacon D; Thoms JA; Poulos RC; Shlien A; Beck D; Campbell PJ; Pimanda JE; Wong JW
Genome Biol; 2014; 15(10):485. PubMed ID: 25298093
[TBL] [Abstract][Full Text] [Related]
10. LARVA: an integrative framework for large-scale analysis of recurrent variants in noncoding annotations.
Lochovsky L; Zhang J; Fu Y; Khurana E; Gerstein M
Nucleic Acids Res; 2015 Sep; 43(17):8123-34. PubMed ID: 26304545
[TBL] [Abstract][Full Text] [Related]
11. Second call for pan-cancer analysis.
Nat Genet; 2014 Dec; 46(12):1251. PubMed ID: 25418742
[No Abstract] [Full Text] [Related]
12. Systematic Screening of Promoter Regions Pinpoints Functional Cis-Regulatory Mutations in a Cutaneous Melanoma Genome.
Poulos RC; Thoms JA; Shah A; Beck D; Pimanda JE; Wong JW
Mol Cancer Res; 2015 Aug; 13(8):1218-26. PubMed ID: 26082173
[TBL] [Abstract][Full Text] [Related]
13. Recurrent somatic mutations in regulatory regions of human cancer genomes.
Melton C; Reuter JA; Spacek DV; Snyder M
Nat Genet; 2015 Jul; 47(7):710-6. PubMed ID: 26053494
[TBL] [Abstract][Full Text] [Related]
14. Highly recurrent TERT promoter mutations in human melanoma.
Huang FW; Hodis E; Xu MJ; Kryukov GV; Chin L; Garraway LA
Science; 2013 Feb; 339(6122):957-9. PubMed ID: 23348506
[TBL] [Abstract][Full Text] [Related]
15. Identification and computational analysis of gene regulatory elements.
Taher L; Narlikar L; Ovcharenko I
Cold Spring Harb Protoc; 2015 Jan; 2015(1):pdb.top083642. PubMed ID: 25561628
[TBL] [Abstract][Full Text] [Related]
16. Exome-Scale Discovery of Hotspot Mutation Regions in Human Cancer Using 3D Protein Structure.
Tokheim C; Bhattacharya R; Niknafs N; Gygax DM; Kim R; Ryan M; Masica DL; Karchin R
Cancer Res; 2016 Jul; 76(13):3719-31. PubMed ID: 27197156
[TBL] [Abstract][Full Text] [Related]
17. Integration of somatic mutation, expression and functional data reveals potential driver genes predictive of breast cancer survival.
Suo C; Hrydziuszko O; Lee D; Pramana S; Saputra D; Joshi H; Calza S; Pawitan Y
Bioinformatics; 2015 Aug; 31(16):2607-13. PubMed ID: 25810432
[TBL] [Abstract][Full Text] [Related]
18. Whole-exome sequencing reveals recurrent somatic mutation networks in cancer.
Liu X; Wang J; Chen L
Cancer Lett; 2013 Nov; 340(2):270-6. PubMed ID: 23153794
[TBL] [Abstract][Full Text] [Related]
19. Telomerase reverse transcriptase promoter alterations across cancer types as detected by next-generation sequencing: A clinical and molecular analysis of 423 patients.
Schwaederle M; Krishnamurthy N; Daniels GA; Piccioni DE; Kesari S; Fanta PT; Schwab RB; Patel SP; Parker BA; Kurzrock R
Cancer; 2018 Mar; 124(6):1288-1296. PubMed ID: 29211306
[TBL] [Abstract][Full Text] [Related]
20. Beyond the exome: the role of non-coding somatic mutations in cancer.
Piraino SW; Furney SJ
Ann Oncol; 2016 Feb; 27(2):240-8. PubMed ID: 26598542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]